StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
AGTX

Agentix Corp.

AGTX OTC Biological Products, (No Diagnostic Substances) EDGAR ↗
$0.02
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap
$801K
Revenue (TTM)
$0.00
Net income (TTM)
-$486K
EPS (TTM)
$-0.01
P/E ratio
Dividend yield
Free cash flow
-$110K
Cash
$771
Total assets
$771
Gross margin
52-week range
$0.01 – $0.06

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-K Fiscal year ended 2026-03-31 Jul 1, 2026 10-Q Quarter ended 2025-12-31 Feb 17, 2026 10-Q Quarter ended 2025-09-30 Nov 20, 2025 10-Q Quarter ended 2025-06-30 Aug 22, 2025 10-K Fiscal year ended 2025-03-31 Jul 16, 2025 10-Q Quarter ended 2024-12-31 Feb 18, 2025 10-Q Quarter ended 2024-09-30 Nov 18, 2024 10-Q Quarter ended 2024-06-30 Sep 25, 2024 10-K Fiscal year ended 2024-03-31 Aug 30, 2024 10-Q Quarter ended 2023-12-31 Feb 14, 2024 10-Q Quarter ended 2023-09-30 Nov 20, 2023 10-Q Quarter ended 2023-06-30 Aug 22, 2023 10-K Fiscal year ended 2023-03-31 Jul 14, 2023 10-Q Quarter ended 2022-12-31 Feb 14, 2023 10-Q Quarter ended 2022-09-30 Nov 14, 2022 10-Q Quarter ended 2022-06-30 Aug 11, 2022 8-K Director or officer change Jun 14, 2022 10-Q Quarter ended 2022-02-28 Apr 13, 2022 10-Q Quarter ended 2021-11-30 Jan 13, 2022 8-K Regulation FD disclosure Dec 21, 2021 10-K Fiscal year ended 2021-08-31 Oct 7, 2021 8-K Completed an acquisition or disposition Jul 16, 2021 8-K Entered a material agreement Jul 14, 2021 10-Q Quarter ended 2021-05-31 Jul 9, 2021 8-K Director or officer change Jun 4, 2021 8-K Entered a material agreement May 27, 2021 10-Q Quarter ended 2021-02-28 Mar 29, 2021 10-Q Quarter ended 2020-11-30 Jan 13, 2021 10-K Fiscal year ended 2020-08-31 Dec 9, 2020 10-K/A Fiscal year ended 2019-08-31 Nov 23, 2020 8-K/A Completed an acquisition or disposition Sep 9, 2020 8-K Other events Jul 30, 2020 10-Q Quarter ended 2020-05-31 Jul 13, 2020 8-K Director or officer change Jul 8, 2020 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Change in control May 29, 2020 8-K Director or officer change May 13, 2020 10-Q Quarter ended 2020-02-29 Apr 27, 2020 10-Q Quarter ended 2019-11-30 Jan 16, 2020 10-K Fiscal year ended 2019-08-31 Dec 5, 2019 10-Q Quarter ended 2019-05-31 Jul 15, 2019